Role of the Linker Domain and the 203–214 N-Terminal Residues in the Human Topoisomerase I DNA Complex Dynamics  by Chillemi, G. et al.
Role of the Linker Domain and the 203–214 N-Terminal Residues in the
Human Topoisomerase I DNA Complex Dynamics
G. Chillemi,* M. Redinbo,y A. Bruselles,*z and A. Desideriz
*CASPUR, Consortium for Supercomputing in Research, Via dei Tizii 6b, Rome, Italy; yDepartment of Chemistry, Department of
Biochemistry and Biophysics, University of North Carolina at Chapel Hill, North Carolina; and zINFM and Department of Biology,
University of Rome ‘‘Tor Vergata’’, Via della Ricerca Scientiﬁca, Rome, Italy
ABSTRACT The inﬂuence of the N-terminal residues 203–214 and the linker domain on motions in the human topoisomerase
I-DNA complex has been investigated by comparing the molecular dynamics simulations of the system with (topo70) or without
(topo58/6.3) these regions. Topo58/6.3 is found to ﬂuctuate more than topo70, indicating that the presence of the N-terminal
residues and the linker domain dampen the core and C-terminal ﬂuctuations. The simulations also show that residues 203–207
and the linker domain participate in a network of correlated movements with key regions of the enzyme, involved in the human
topoisomerase I catalytic cycle, providing a structural-dynamical explanation for the better DNA relaxation activity of topo70
when compared to topo58/6.3. The data have been examined in relation to a wealth of biochemical, site-directed mutagenesis
and crystallographic data on human topoisomerase I. The simulations ﬁnally show the occurrence of a network of direct and
water mediated hydrogen bonds in the proximity of the active site, and the presence of a water molecule in the appropriate
position to accept a proton from the catalytic Tyr-723 residue, suggesting that water molecules have an important role in the
stabilization and function of this enzyme.
INTRODUCTION
Topoisomerases are a ubiquitous family of enzymes essential
for the control of DNA supercoiling generated by replication,
transcription, and recombination. Eukaryotic topoisomerase
I enzymes relax DNA superhelical tension by introducing
a transient single-strand break in one strand of duplex DNA
and forming a covalent phosphotyrosyl bond with the 3#-end
of the broken DNA strand. The covalent topoisomerase-
DNA complex is the molecular target of the anti-tumor drug
camptothecin (CPT) (Pommier et al., 1999) that stabilizing it
produces DNA damage after collisions with replication forks
or transcription complexes (Pommier et al., 2003). Human
topoisomerase I is composed by four domains: the N-ter-
minal, the core (formed by three subdomains), the linker, and
the C-terminal domain, which includes the catalytic tyrosine
723. Several crystal structures of N-terminal truncated forms
of the protein have revealed that the enzyme wraps com-
pletely around duplex DNA to induce a single-strand break.
The topoisomerase I catalytic cycle is composed of ﬁve
subsequent steps: DNA binding; DNA cleavage; relaxation
of superhelical tension; DNA religation; and DNA release
(Pommier et al., 1998). During these steps the enzyme goes
through large conformational variations without any need for
energy cofactors, from an ‘‘open’’ structure that allows the
DNA binding, to the ‘‘close’’ conformations observed by
x-ray diffraction in which the enzyme completely embraces
the DNA. The importance of topoisomerase I ﬂexibility in
the modulation of the enzymatic catalysis has been elegantly
pointed out by two recent works describing the properties of
the enzyme cross-linked through a disulﬁde bridge either at
the salt-bridge loops (Carey et al., 2003) or at the active-site
proximal loops (Woo et al., 2003).
The large conformational dynamics implied by the
catalytic cycle of the enzyme can in principle be described
through MD simulations designed to investigate the
structural and dynamical properties of proteins and nucleic
acids (Tsui et al., 2000; MacKerell and Nilsson, 2001;
Giudice and Lavery, 2002). Recently, we have used this
approach to investigate a covalent human topoisomerase
I-DNA complex involving a form of the enzyme lacking the
N-terminal domain (resides 1–214) and linker domain
(residues 627–719; topo58/6.3). These studies provided
information on the protein-DNA interactions and the role of
water in protein-DNA recognition and in catalysis (Chillemi
et al., 2001), and permitted us to demonstrate the occurrence
of intra- and interdomain communications between topo58/
6.3 regions (Chillemi et al., 2003).
Recent structural and functional data have highlighted
the importance of the N-terminal residues 203–214 and the
linker domain on topoisomerase I activity and CPT sen-
sitivity (Stewart et al., 1999; Ireton et al., 2000; Redinbo et al.,
2000; Lisby et al., 2001; Frohlich et al., 2004). Moreover,
certain conformations of the enzyme appear able to perturb
the dynamical properties of the linker domain. For example,
this domain is disordered in many binary topoisomerase
I-DNA complexes (e.g., Redinbo et al., 1999; Staker et al.,
2002), but it is visible in the ternary complex of human
topoisomerase I, DNA ,and the camptothecin analog topo-
tecan (Staker et al., 2002). In accordance with this, we have
recently shown that a mutation within the linker domain that
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confers CPT resistance increases greatly the mobility of this
domain (Fiorani et al., 2003). Thus, it is clear from several
lines of evidence that the linker domain and regions of the
N-terminal domain play important roles in the catalytic
action of topoisomerase I.
We have now investigated the impact of the N-terminal
residues 203–214 and the linker domain on the dynamics of
human topoisomerase I by comparing the topo70-DNA
covalent complex (containing these regions) with the
topo58/6.3-DNA covalent complex (Fig. 1). Simulations of
the topo70 system revealed a complex network of correlated
and anticorrelated motions not observed in the topo58/6.3-
DNA system. These observations suggest that only the form
of the enzyme containing amino acids 203–765 can ac-
curately control all steps of catalysis, particularly the DNA
strand cleavage and the proposed controlled rotation re-
laxation of DNA supercoils.
METHODS
The starting coordinates of the topo58/6.3-DNA covalent complex were
obtained from the crystal structure 1a31 (Redinbo et al., 1998). The topo70-
DNA covalent complex was modeled obtaining the starting position for
residues 215–633 and 641–765 from the crystal structure 1a36 (Stewart et al.,
1998), and those for residues 203–214 from the crystal structure 1ej9
(Redinbo et al., 2000). The ﬁve residues constituting the loop region that
connects the linker to the core domain (residues 636–640), which are lacking
in the 1a36 Protein Data Bank (PDB) structure because of thermal
ﬂuctuation, and the covalent bond between Tyr-723 and the DNA-1 base
were added to the system by molecular modeling. The spatial environment of
each new residue was checked for close contact or overlap with neighboring
residues and stereochemical regularization of the structures was obtained by
the Powell minimization method implemented in the SYBYL program
(Tripos, St. Louis, MO). At the moment this procedure was adopted, it
was the only way to obtain a structure of human topoisomerase I residues
203–765 in covalent complex with DNA. Successively, the x-ray structure
of the ternary complex topo70-DNA–Topotecan has been solved (1K4T;
Staker et al., 2002). However, the backbone root mean-square deviations
of our model, respective to the 1K4T x-ray structure, is only 1.6 A˚.
The systems were modeled with the AMBER95 all-atom force ﬁeld
(Cornell et al., 1995) and immersed in a rectangular box (1053 923 99 and
127 3 84 3 108 A˚3 for topo58/6.3 and topo70, respectively) ﬁlled with
TIP3P water molecules (Jorgensen et al., 1983). The protein residue
ionization state has been assigned considering the most probable one at
neutral pH, i.e., lysine and arginine residues are protonated; aspartate and
glutamate residues are deprotonated; histidine residues are half protonated.
Na1 counterions have been added to make the system electro-neutral. The
resulting total systems contained 7,679 protein atoms, 1,401 DNA atoms,
27Na1 counterions, and23,216watermolecules for topo58/6.3, giving a total
of 78,755 atoms; 9417 protein atoms, 1,401DNAatoms, 21Na1 counterions,
and 28,313 water molecules for topo70, giving a total of 95,778 atoms. It is
worth noting that these great dimensions ask for efﬁcient parallel computers
to be simulated. Simulation of the topo70-DNA complex for 3250 ps has
required, for example, 408 h of wall clock time on 8 CPUs of the IBM sp4
(Power4 @ 1.3 GHz). The systems were simulated in periodic boundary
conditions, using a cutoff radius of 9 A˚ for the nonbonded interactions, and
updating the neighbor pair list every 10 steps. The electrostatic interactions
were calculated with the particle mesh Ewald method (Darden et al., 1993;
Cheatham et al., 1995). The SHAKE algorithm (Ryckaert et al., 1977) was
used to constrain all bond lengths involving hydrogen atoms. Optimization
and relaxation of solvent and ions were initially performed keeping the solute
atoms constrained to their initial position with decreasing force constants of
500, 25, 15, and 5Kcal/(mol A˚). The systems have been simulated for 3250 ps
at a constant temperature of 300 K using Berendsen’s method (Berendsen
et al., 1984) and at a constant pressure of one barwith a 2 fs time step. Pressure
and temperature coupling constants were 0.5 ps. The analyses reported in this
manuscript refer to the last 3000 ps of the trajectory (i.e., from 250 to 3250
ps), since the trend of the root mean-square deviations indicates that the
systems were well stabilized after 250 ps.
The dynamic cross-correlation (DCC) maps of the systems were built
with in-house written code, taking into account the coordinates of the protein
C-a atoms since they contain enough information to describe the largest
system motions. The elements of the dynamic cross-correlation map (Cij)
were computed as:
Cij ¼ ÆDri 3 Drjæﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ÆDr2i æ
q
3
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ÆDr2j æ
q ;
where Dri is the displacement from the mean position of the ith atom and the
Æ æ represent the time average over the whole trajectory (Mc Cammon and
Harvey, 1987). Positive Cij values represent a correlated motion between
residues i and j (i.e., the residuesmove in the same direction). Negative values
of Cij represent an anticorrelated motion between residues i and j (i.e., they
move in opposite directions). The order parameter and the direct hydrogen
bonds have been calculated using the GROMACSMDpackage version 3.1.4
(Berendsen et al., 1995). The water-mediated hydrogen bond calculation was
made using an in-house written code, based on the GROMACS code.
RESULTS AND DISCUSSION
Backbone ﬂuctuations
The per residue backbone ﬂuctuations for the topo70 and
topo58/6.3 systems are shown in Fig. 2. Topo58/6.3
FIGURE 1 (A) Topo58/6.3 human topoisomerase I structure in complex
with duplex DNA. Core Subdomains I, II, and III are rendered in cyan,
magenta, and blue, respectively, whereas the C-terminal domain is in green
and the DNA duplex in yellow. (B) Topo70 human topoisomerase I structure
in complex with duplex DNA. Colors are as in panel A, with the addition
of the linker domain in red. The active site residues are shown in light and
dark gray.
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ﬂuctuates more than topo70 (average ﬂuctuation of 4.1 A˚ vs.
3.5 A˚) even though the linker domain in topo70 contains the
residues with the largest range of ﬂuctuation, reaching values
higher than 7 A˚ in the loop connecting helices 18 and 19
(Fig. 1 B). Such observations indicate that the presence of the
linker domain and of the N-terminal residues dampen the
ﬂuctuations of the core and C-terminal domains. A similar
trend is observed in the crystallographic thermal displace-
ment parameters (B-factors), an experimental measure of
protein mobility. The linker domain in the 1a36 crystallo-
graphic structure is the most mobile region (average B-factor
of 60.5 A˚2) and its presence reduces the relative B-factors
of the core and C-terminal domains. The mean B-factors of
the core and C-terminal domain are 37.3 and 42.6 A˚2,
respectively, in the presence of the linker domain, whereas in
the absence of the linker domain (crystallographic structure
1a31) the mean B-factors are 48.3 and 55.0 A˚2, respectively.
The mean B-factors over all atoms for the topo70-DNA
(1a36) and topo58/6.3-DNA (1a31) complex structures are
48.9 and 40.9 A˚2, respectively.
The presence of the linker domain also dampens in-
dividual ﬂuctuations within the human topoisomerase I DNA
complex. For example, ﬂuctuations in topo58/6.3 are
characterized by more extreme minima and maxima values
than in topo70 (Fig. 2). This phenomenon is more evident in
core subdomain I, where topo70 has average and standard
deviation ﬂuctuations of 3.2 and 0.2 A˚, whereas the re-
spective topo58/6.3 values are 4.0 and 0.9 A˚ (Fig. 2). In both
systems, Asn-345 and Asp-389 are the most ﬂuctuating
residues in this protein region, but their ﬂuctuations are
greatly reduced in topo70. The most dramatic dynamical
changes occur in the region located between these two
residues. Arg364, in fact, has very low ﬂuctuations in
topo58/6.3 but not in topo70. Analyses presented below
conﬁrm these data, indicating that the linker domain and the
N-terminal residues strongly perturb the dynamics of the
Phe-361–Lys-369 region that constitutes lip1, one of the two
lips on the core of the enzyme that clamp around DNA. The
ﬂuctuations of core subdomain II are also strongly dampened
(Fig. 2). The average ﬂuctuations and standard deviation of
this subdomain are 3.0 and 0.3 A˚, respectively, in topo70
compared with 3.6 and 0.8 A˚, respectively, in topo58/6.3.
The decrease of the average ﬂuctuations and standard
deviation is nearly the same in core subdomain III (average
and standard deviation ﬂuctuations of 3.5 and 0.3 A˚,
respectively, in topo70, versus 4.2 and 0.8 A˚ in topo58/6.3)
(Fig. 2). In this protein region, some key residues maintain
the same relative behavior in both simulations (e.g., 519–520
and 608–609, which show high ﬂuctuations, and Asp-533,
which exhibits low ﬂuctuations). Asp-533 is the only protein
residue found crystallographically to contact directly the
camptothecin derivative Topotecan (Staker et al., 2002).
The C-terminal domain ﬂuctuates less in topo70 than in
topo58/6.3 (average and standard deviation ﬂuctuations of
3.3 and 0.2 A˚, respectively, in topo70, versus 3.9 and 0.6 A˚
in topo58/6.3) and the relative maxima and minima
ﬂuctuations are almost completely maintained (Fig. 2). The
DNA ﬂuctuations do not show signiﬁcant difference in the
two simulations, with average ﬂuctuations and standard
deviation of 3.4 and 0.9, respectively, in topo58/6.3, versus
3.5 and 0.7 A˚ in topo70. This agrees with the mean
crystallographic B-factors of DNA atoms, which are 47.1
and 48.3 A˚2, respectively, for 1a31 and 1a36 crystallo-
graphic structures.
S2 parameter for U/W dihedral angles
The ﬂexibility of the protein backbone has also been
examined through the calculation of an order parameter S2,
which is related to the proteinF/C backbone dihedral angles
(Van der Spoel and Berendsen, 1997). S2 gives a measure of
the ﬂexibility of the backbone, being 1 in a completely rigid
system, or 0 in a system where all the possible conformations
are sampled. The order parameter for topo70 and topo58/6.3,
shown in Fig. 3, indicates that the backbone of both struc-
tures is quite rigid, with relatively few residues exhibiting
S2 values ,0.7.
In topo70, Glu-213 and Gly-214, two residues not present
in the topo58/6.3 simulation, display a very high ﬂexibility,
with the S2 values for their respective C and F dihedral
angles being 0.26 and 0.28. These residues are located at the
C-terminal of the 12 N-terminal residues that were ﬁrst
detected through x-ray diffraction in the topo58/6.3-DNA
complex where a cytosine rather than the favored thymine is
present at the1 position of the scissile strand (PDB id 1ej9;
Redinbo et al., 2000). These residues have since been
observed in other structures of topo70 in complex with DNA
FIGURE 2 Per residue root mean-square ﬂuctuations for topo70 (full line)
and topo58/6.3 (dotted line). Residues with high or low ﬂuctuations are
indicated.
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(e.g., 1K4T, 1K4S, Staker et al., 2002; 1NH3, Chrencik et al.,
2003; 1LPQ, Lesher et al., 2002). Inspection of the
Ramachandran plots shows that Glu-213/Gly-214 visit two
different backbone conformations sampled for 1000 ps and
2000 ps of simulation time (data not shown).
The Asn-352/Phe-353 region is ﬂexible in both topo70
and topo58/6.3. In the topo70 simulation, the S2 value for the
respective C/F dihedral angles are slightly lower than the
corresponding values in topo58/6.3 (0.36/0.58 in topo70 vs.
0.70/0.77 in topo58/6.3), indicating that in both systems
a great number of C angle values are sampled by Asn-352
during the simulation. The high ﬂexibility of the Asn-352
backbone may be related to the antitumor activity of SN-38
(a camptothecine analog) relative to the parent compound.
Upon mutation of Asn-352 to alanine, SN-38 shows a
decreased ability to poison the human topoisomerase I-DNA
complex, whereas CPT’s efﬁcacy is unchanged. It has been
suggested that the loss of a direct hydrogen bond be-
tween Ala-352 and the A-ring 10-OH atom, present in SN-38
but not in CPT, may explain this observation (Laco et al.,
2002). Asn-352 is located adjacent to the A ring 9-group
CH2-N(CH2)2, in the recently solved ternary topo70-DNA-
Topotecan 3D structure (Staker et al., 2002) and not
hydrogen-bonded to the 10-OH atom, which is also present
in Topotecan. Despite the absence of this bond, the
proximity of Asn-352 to the 9- and 10-position on the
camptothecins suggests that the backbone ﬂexibility of this
residue observed in our simulations could play an important
role in topoisomerase-camptothecin drug interactions. It is
interesting to note that, despite the ﬂexibility of its main
chain, the side chain of Asn-352 forms two stable hydrogen
bonds with Tyr-426 and Met-428 in both simulations.
The backbone dynamics of Arg-364 and Gly-365 show
a high ﬂexibility in topo70 (Arg-364 S2 values of 0.35 and
0.27 forF andC, respectively; Gly-365 S2 values of 0.43 for
C) but not in topo58/6.3 (Arg-364 S2 values of 0.93 and 0.92
for F andC, respectively; Gly-365 S2 values of 0.83 forC),
demonstrating an inﬂuence of the linker domain in the
motion of these residues. As already pointed out, Arg-364
is less ﬂuctuating in topo58/6.3 than in topo70 (2.4 vs. 3 A˚;
see Fig. 2). The order parameter analysis shows that the
increased ﬂuctuation in topo70 is coupled to a dramatic
increase in the backbone ﬂexibility of this residue. The
position of Arg-364 appears to be critical to the productive
binding of the camptothecins to human topoisomerase I
(Staker et al., 2002; Chrencik et al., 2004).
High ﬂexibility is also found in the Asn-491/Thr-501 lip2
region of core subdomain III in topo70 but not in topo58/6.3.
Several lip2 residues in topo70, in fact, show S2 values lower
than 0.8, (minimum of 0.53/0.57 for the Glu-495/Gly-496
C/F dihedral angles), whereas only Asp-500 shows an S2
value equal to 0.7 in topo58/6.3. The average ﬂuctuations
of lip2 residues are also increased in topo70 compared to
topo58/6.3 (see Fig. 2). Therefore, the two lips show a similar
behavior: low ﬂuctuations and rigid backbone in topo58/6.3;
large ﬂuctuations, although always less than the average; and
ﬂexible backbone in topo70.
The Asp-519/Gly-520 couple is very ﬂexible in both
systems, with C/F S2 values lower than 0.5 (see Fig. 3).
These residues, located in the loop between b12 and b13,
display relative maximum ﬂuctuations followed by a relative
minimum at the Asp-533 residue (see Fig. 2). It is interesting
to notice that these well-conserved dynamical features in-
volve a region containing essential residues, such as Asp-533,
FIGURE 3 f/c Order Parameter S2 for topo70
(upper panel) and topo58/6.3 (lower panel). f and c
dihedral angles are represented in full and dotted lines,
respectively. Residues with low S2 value are indicated,
with their respective f/c S2 value in brackets (bold
characters are used for c dihedral angles).
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whose mutation in Gly or Asn produces CPT resistance
(Andoh et al., 1987; Tamura et al., 1991; Saleem et al., 1997),
or Lys-532, the only amino acid forming a base-speciﬁc
contact with DNA (Redinbo et al., 1998, 2000). Asp-533 is
the only amino acid side chain that directly contacts the
camptothecin analog topotecan, as observed in a crystal
structure of the topoisomerase I-DNA-topotecan complex
(Staker et al., 2002). The principal component analysis,
a technique used to identify large collective protein move-
ments connected to functional properties, showed that the
ﬂexibility in the Asp-519/Gly-520 backbone of topo58/6.3 is
functionally connected to the motion of the b12-b13-b14
sheet (Chillemi et al., 2003, and supplementary material
therein). This movement permits the direct insertion and
removal of helix 13, containing Lys-532 and Asp-533, in the
DNA minor groove and its participation in the active site
orientation (Chillemi et al., 2003).
The backbone of Leu-568/Asn-569 is also signiﬁcantly
ﬂexible in topo70, being 0.74/0.58 the S2 values for their
respectiveC/F dihedral angles, but not in topo58/6.3. These
residues connect the 550–567 region, which exhibits motion
strongly correlated with the linker domain (see below), to
helix 15 (residues 570–580). The backbone ﬂexibility of
Leu-568/Asn-569 permits the uncoupling of the motion
between helix 15 and the 550–567 region in topo70. In
contrast, such ﬂexibility is not observed in topo58/6.3, since
the deletion of the linker domain abolishes the stimulus on
the 550–567 region. On the other hand, Glu-582/Gly-583
have low S2 values in topo58/6/3 (0.50/0.42 for the
respective C/F dihedral angles), and rigid backbone in
topo70 (0.92/0.90 S2 values for the respective C/F dihedral
angles). The backbone ﬂexibility of Glu-582/Gly-583 per-
mits the mechanical uncoupling of helices 16 and 15.
The linker domain, the most ﬂuctuating region in topo70,
does not have a ﬂexible backbone because its two long
helices appear to move as a whole and to not contain a hinge
residue. The residues with lower S2 value are Thr-706 and
Thr-639. The latter one is located in the loop connecting the
core with the linker domain that is disordered in the 1a36
PDB structure. The C-terminal domain is quite rigid in its
backbone motion and the S2 values are very similar in the
two simulations, with a lower S2 value located on Asp-760.
DCC map
The dynamic cross correlation (DCC) map for the two
simulations is shown in Fig. 4. The map values (Cij) are
a measure of the correlated motion between residues i and j.
Positive Cij values are indicative of strong correlation in the
movement of residues i and j in the same direction, whereas
negative Cij values denote that the two residues move along
opposite direction (anticorrelated motion). The analysis has
been carried out on the protein Ca atoms since they contain
enough information to describe the largest protein motions.
The intensity of the correlation has been color coded, as
described in Fig. 4, where the 563 Cij values for topo70
(residues 203–765) are reported in the upper left triangle of
Fig. 4, and the corresponding 458 Cij values for topo58/6.3
(residues 215–626 and 720–765) in the lower right triangle.
The dimensions of the systems (;100,000 atoms) and the
intrinsic ﬂexibility of the topoisomerase enzyme exclude the
possibility to visit, during the simulation, the whole
conformational space available to the protein. Nevertheless,
the DCC map analyses provided useful information,
highlighting the role of speciﬁc residues in the protein-
protein and protein-DNA communications (Chillemi et al.,
2003; Reddy et al., 2003). In the following, we will limit our
description to the DCC map peaks having an absolute value
.0.5, that are observed after 2 ns (data not shown) and remain
greater than the cutoff after 2.5 (data not shown) and 3 ns (Fig.
4), under the hypothesis that they represent the main motion
ﬁngerprint of the system. These peaks are also identiﬁed in
a comparative analysis concerning the ﬁrst (0.25–1.75 ns) and
second (1.75–3.75 ns) halves of the trajectory. Therefore we
will not discuss correlation peaks observed after 3 ns that were
not already higher than the cutoff in the previous times.
The three-dimensional structure of the 12 amino terminal
residues show that they lie close to helix 8 (residues 434–
453), which has been hypothesized to be a hinge in the
clamping of the enzyme around DNA (Redinbo et al., 2000).
It is not surprising, then, to observe a strong correlation in the
motion of residues 203–207 with residues 430–448 in helix 8
(see ellipse A in Fig. 4). The same N-terminal residues show
direct correlated motions with the catalytic region of Tyr-723
and residues 743–755 in helices 23 and 24 of the C-terminal
domain, highlighted in ellipse C. These last two correlated
motions cannot be explained by direct contacts and they
imply a long-range communication. In fact, the sole stable
protein-protein hydrogen bond between residues 203–214
and the rest of the protein is formed by Trp-206 and Asp-
757, for 82% of the simulated time. Moreover, residues 203–
207 show signiﬁcant anticorrelated motions with residues
677–693, i.e., with the N-terminal portion of helix 19 in the
linker domain (ellipse B).
Residues of the linker domain show different dynamics
depending on their position. The N-terminal portion of the
domain (residues 636–648) has correlated motion with its
C-terminal portion (residues 698–712), highlighted in square
D. Both these regions have correlated motion with the
C-terminal portion of the core subdomain III, as highlighted
by rectangles E and F. The motion highlighted in rectangle E
involves a region of core subdomain III (residues 595–627)
smaller than rectangle F (residues 597–634), indicating that
only the N-terminal portion of the linker domain exerts
a direct inﬂuence on the catalytic His-632 dynamics.
The central portion of the linker domain (residues 657–
691) behave like a rigid body, with high correlated motions
among its residues (DCC map values always .0.7 and
frequently.0.85, respectively, in yellow and red color in Fig.
4). This portion of the linker domain shows anticorrelated
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motions with the N-terminal portion of the linker itself, the
whole C-terminal domain, the C-terminal portion of the core
subdomains III (squareG) and residues 429–448, in helix 8 of
core subdomain III (highlighted in rectangle J), proposed as
the region involved in the opening and closure of the enzyme
around the DNA (Redinbo et al., 1998). The same portion
of the linker domain shows correlated motions with the
C-terminal and N-terminal portions of the region contain-
ing the b12-b13-b14 sheet and helix 13 (highlighted by
rectangles H and I, respectively).
Helix 8, besides the anticorrelated motion with the linker
domain and the correlated one with the N-terminal residues
203–207, shows correlated motion with nearly the whole
C-terminal domain (highlighted in rectangle K) and with
residues 581–602 in helix 16 of the core subdomain III
(highlighted in rectangle L), containing the catalytic residue
Arg-590.
Inspection of topo70 DCC map reveals a network of
strong correlated and anticorrelated motions among key
residues. These correlated motions involve most of the
protein regions indicated as playing a role in the enzymatic
cycle (Redinbo et al., 1998; Stewart et al., 1998; Frohlich
et al., 2004): the C-terminal domain, in particular the Tyr-
723 catalytic region; the linker domain; helix 8 in core
subdomain III; the 203–207 N-terminal residues. In topo58/
6.3 correlated motions between helix 8 in core subdomain III
and the whole C-terminal domain or helix 16 are completely
absent, whereas the whole topo70 form of the enzyme show
very high peaks (highlighted in rectangles K and L, re-
spectively), providing a structurally dynamical interpreta-
tion for its highest DNA relaxation activity (Stewart et al.,
1997; Lisby et al., 2001). Indeed, topo58/6.3 and all the
enzyme forms in which the linker domain has been disabled
show an increase in the religation rate, and a distributive
behavior, i.e., they produce many partially relaxed topo-
isomers, reﬂecting a reduced afﬁnity for DNA (Ireton et al.,
2000; Fiorani et al., 2003).
Hydrogen bonding at the active site
Analysis of the simulations in proximity of the active site
indicates the occurrence of a stable network of hydrogen
FIGURE 4 Dynamic cross correla-
tion map for the topo70 (upper left
triangle) and topo58/6.3 (lower right
triangle). Correlated values with 0.55
# Cij, 0.70, 0.70 # Cij , 0.85 and
0.85# Cij, 1 are represented in green,
yellow, and red, respectively, whereas
the anticorrelation values 0.70 # Cij
, 0.55 and 0.8 # Cij , 0.70 are
represented in cyan and blue, respec-
tively. The correlation range 0 # Cij ,
0.55 and the anticorrelation range
0.55 # Cij , 0 are represented in
a gray scale depending on the absolute
value of the correlation. The value 1,
along the diagonal (correlation of the
residue with itself), is represented in
black.
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bonds, both direct and water mediated, that likely plays an
important role in the communication between protein and
DNA. The presence of long residence water molecules is
particularly interesting since a catalytic mechanism has been
proposed where the solvent molecule would serve as
a speciﬁc base to activate the catalytic Tyr-723 residue
(Stewart et al., 1998; Redinbo et al., 2000; Bailly, 2003).
Molecular dynamics simulation of the topo58/6.3-DNA
complex supports this hypothesis since four out of 17 long
residence water molecules are localized in the proximity of
the active site, indicating that this region behaves as a water
attractor (Chillemi et al., 2001). Moreover, one of these
water molecules is hydrogen bonded to the phosphate group
involved in the covalent attachment of Tyr-723 to the 1
DNA scissile base (PTR723), and therefore in the appropri-
ate position to participate to the catalytic reaction (Chillemi
et al., 2001).
Signiﬁcantly, a water molecule is present also in the
topo70 active site (shown in Fig. 5), for nearly all the
simulation time, again in an appropriate position to accept
a proton from Tyr-723. This water molecule forms the
following water mediated bonds: PTR723-His-632,
PTR723-Arg-488 and Arg-488–His-632 for 91%, 84%,
and 79% of simulation time, respectively. Moreover, both
Arg-590 and Lys-532 are hydrogen bonded with a single
water molecule for 89 and 93% of simulation time, re-
spectively, thus contributing to maintaining long-residence
water molecules in the active site region. These results
indicate a synergistic role for Tyr-723, Arg-488, Arg-590,
Lys-532, and His-632 residues in the formation and
stabilization, together with water molecules, of the pentaco-
valently coordinated transition state, as already suggested by
crystallographic data and biochemical experiments (Bailly,
2003).
Fig. 5 shows a snapshot of the topo70 active site
representative of the simulation, in which the majority of
the stable hydrogen bonds involving protein residues and
DNA bases around the topoisomerase active site are high-
lighted. In detail, the phosphate group covalently bonded
to PTR723 forms with its O1P oxygen two direct hydrogen
bonds with the 11 A 5#-OH, and with Arg590 for the 94%
and 96% of the simulation time, respectively. The 11 A 5#-
OH also forms a water-mediated hydrogen bond with the
phosphate PTR group, although only for 11% of the simula-
tion time. These two bonds could be signiﬁcant in the religa-
tion phase of catalysis when the 5# oxygen must reform the
covalent bond with the phosphate group.
Lys-532 plays an important role in the catalytic reaction,
recently better clariﬁed by means of mutagenesis experi-
ments (Interthal et al., 2004). This residue contacts the O2
atom of the scissile base in the crystallographic structures of
both topo58/6.3 (PDB id 1a31 and 1a35) and topo70 (PDB
id 1a36, 1ej9, 1nh3, 1k4s, 1k4t, 1lpq) but mutation of Lys-
532 in arginine or alanine has demonstrated that this
interaction is not required for DNA sequence speciﬁcity
(Interthal et al., 2004). The same study indicates that Lys-
532 behaves as a general acid, in the cleavage reaction,
protonating the leaving 5# oxygen. Both the topo58/6.3 and
topo70 simulations conﬁrm the direct stable hydrogen bond
between Lys-532 and the O2 atom of the 1 scissile base,
but the topo70-DNA complex simulation shows three other
Lys532-DNA contacts: with the O4# atom of the 11 A base
in the scissile strand, for 51% of the simulation time; with the
N3 atom of the A1 base in the intact strand, for 10% of the
simulation time; and with the N3 atom of the A 2 base
in the intact strand, for 81% of the simulation time. In-
terestingly, all the topo70 crystallographic structures show
that Lys-532 is able to contact several DNA bases, either in
the scissile (1 and11 bases) or in the intact strand (2 and
3 bases).
In several crystallographic structures of topo70 (PDB id
1a36, 14ks, 1k4t) the side chain of Thr-718 is hydrogen
bonded with the phosphate group of G 12 of the scissile
strand. Staker and coauthors suggest that this interaction may
help the positioning of the 11 5#-OH to allow the
nucleophilic attack of PTR723 in the religation step (Staker
et al., 2002), thus explaining the lethal phenotype of a Thr-
718 to Ala mutation that kills the cell upon stabilizing the
topoisomerase-DNA covalent intermediate, similarly to CPT
(Fiorani et al., 1999). The topo70-DNA complex simulation
not only conﬁrm the high stability of the hydrogen bond
between Thr-718 and the G12 phosphate group, present for
the whole simulation, but it also shows that the catalytic
residues Arg-488 and His-632 form additional highly stable
hydrogen bonds with the same phosphate group (Fig. 5),
indicating that the enzyme accurately controls the relative
position of the 11 base with regard to the active site, by
means of several direct hydrogen bonds with the 12 G
phosphate group.
The importance of Asn-722 has been demonstrated by
several experimental studies. Mutation of this residue to
leucine results in a decrease of enzymatic activity, whereas
its mutation to Ala leads to resistance to CPT and other
topoisomerase poisons (Knab et al., 1993; Knab et al., 1995;
Hann et al., 1998). Mutations to Ser, Asp, or His interfere
with both enzyme activity and drug sensitivity (Leteurtre
et al., 1994; Fertala et al., 2000). Crystal structures of
topoisomerase-DNA covalent complexes indicate that this
residue, depending on the experimental conditions, is able to
form hydrogen bonds with the phosphate oxygen atoms of
1 T (PDB id 1k4s), with the O5# oxygen of11 G (PDB id
1nh3) or with the O4# and O5# oxygen atoms of11 T (PDB
id 1a31). Moreover, the topoisomerase-DNA-Topotecan
ternary structure shows a water mediated contact between
Asn-722 and the Topotecan drug (Staker et al. 2002). Our
simulation shows that Asn-722 can inﬂuence the position of
the two scissile DNA bases (1 and 11), through a direct
hydrogen bond with the OP oxygen atoms of 1 T for the
whole simulation and a water-mediated bond with the N7
atom of 11 A for 80% of the simulation time. These
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observations support the importance of this residue for topo-
isomerase activity and drug sensitivity.
CONCLUSIONS
The simulations reported here highlight the crucial role
played by the linker domain and the N-terminal residues in
human topoisomerase I, allowing us to shed some light on
the complex structural dynamics involved in the action of
this enzyme. The topo70-DNA complex simulation shows
the occurrence of speciﬁc correlated motions that differ
signiﬁcantly from the ones previously found in the topo58/
6.3 simulation (Chillemi et al., 2003). These results
demonstrate that the presence of these regions deeply alters
the dynamics of speciﬁc key protein regions. A dynamical
coupling between the linker domain and the active site can be
envisaged from the x-ray structure of topo70 system in the
presence and absence of Topotecan since the linker domain
cannot be visualized in the binary topoisomerase-DNA
complex but it is visible in the ternary topoisomerase-DNA-
Topotecan complex (Staker et al., 2002). The importance of
the linker domain in modulating the enzyme dynamics has
been established from a series of experiments carried out on
an enzyme having an altered linker domain. In fact,
comparison of the catalytic properties of the topo70 enzyme
and those of a), the linker deleted form topo58/6.3 (Stewart
et al., 1997); b), the topo58/12 form, in which the linker
domain is not covalent bonded to the core domain (Stewart
et al., 1999); c), the topo70DL enzyme, having the region
660–688 deleted, resulting in a shortened linker domain
(Ireton et al., 2000); and d), the single Ala-653Pro mutation
on the linker domain (Fiorani et al., 2003) indicates that all
‘‘linker-disabled’’ topoisomerase forms exhibit:
1. Slight reduction in activity.
2. A cleavage-religation equilibrium shifted toward the
relegation.
3. Reduced DNA binding afﬁnity.
4. Distributive relaxation mode, where the modiﬁed en-
zymes appear to leave the DNA substrate after remov-
ing only a few supercoils at a time.
5. Camptothecin resistance.
Taken together, these observations indicate that the linker
domain perturbs the enzyme dynamics by slowing the
religation step of catalysis, permitting the wild-type enzyme
to remain covalently bound to DNA and enhancing CPT’s
ability to stabilize the covalent protein-DNA intermediate
(Fiorani et al., 2003).
Speciﬁcmotions detected in our simulations can be directly
correlated with experimental results reported in the literature.
In detail, in our simulation residues 203–214 of the N-ter-
minal domain, included in the model, show a disjoined
dynamics from the core domain. The order parameter S2 (Fig.
3) indicates signiﬁcant ﬂexibility of the Glu-213/Gly-214
FIGURE 5 Molecular dynamics
snapshot of the active site region. The
active site residues and bases are high-
lighted in different color; the oxygen
and nitrogen atoms involved in the
hydrogen bonds are represented in red
and blue, respectively. Direct and
water-mediated hydrogen bonds are
represented in black full and dashed
lines, respectively.
4094 Chillemi et al.
Biophysical Journal 87(6) 4087–4097
backbone, whereas the dynamic correlation map (Fig. 4)
shows correlated movement between residues 203–208 and
four key protein regions: helix 8 in core subdomain III
(highlighted in ellipse A); the N-terminal portion of helix
19 in the linker domain (highlighted in ellipse B); the cata-
lytic region around Tyr-723; and helices 22 and 23 in the
C-terminal domain (highlighted in ellipse C). The ﬂexibility
of the Glu-213/Gly-214 backbone, therefore, seems critical
to the involvement of the N-terminal residues 203–208 to
protein communications among essential topoisomerase
regions. Indeed, the inﬂuence of the N-terminal residues
191–206 on the enzyme’s catalytic cycle has been elucidated
by biochemical experiments (Lisby et al., 2001; Christensen
et al., 2003). Recently, the 203–206 region, and in particular
Trp-205, has been shown to participate in the control of the
DNA rotation step (Frohlich et al., 2004), likely by co-
ordinating the function of the linker domain or the nose cone
helices, as was suggested on the basis of structural data
(Redinbo et al., 2000). Our simulation indicates that this
coordinated function can be exerted through the correlation of
the linker domain and the 203–206 N-terminal residues.
The lip1 (Phe-361–Lys-369), one of the two lips that
closes the clamp around the DNA, exhibits signiﬁcantly
different dynamics in topo70 when compared to topo58/6.3.
Arg-364, in particular, shows larger ﬂuctuations (Fig. 2) and
a more ﬂexible backbone (Fig. 3) in topo70. Indeed, the 364–
365 region of topoisomerase I has been shown to inﬂuence
both the enzymatic activity of the enzyme (Li et al., 1997;
Fiorani et al., 1999) and the efﬁcacy of the camptothecins
(Benedetti et al., 1993; Rubin et al., 1994; Li et al., 1997;
Bailly et al., 1999; Fiorani et al., 1999; Urasaki et al., 2001;
Chrencik et al., 2004).
Finally, our simulations strongly reinforce the hypothesis
that helix 8 may play a role in the opening and closing of the
enzyme around DNA (Redinbo et al., 2000). In fact this helix
shows correlated or anticorrelated motions with the follow-
ing key protein regions: the 203–208 N-terminal residues;
the central portion of the linker domain; nearly the whole
C-terminal domain; and helix 16 in core subdomain III,
which contains the catalytic Arg-590. The wider ﬂuctuations
and the absence of such correlated motions in the topo58/6.3
system may account for the distributive behavior of 58/6.3
relative to the processive nature of topo70, i.e., only the
whole form of the enzyme can accurately control the
opening-closing of the enzyme around DNA.
Several aspects of human topoisomerase I dynamics in
relation to function still remain to be examined, however.
One example is the ﬂexibility of the enzyme’s active site and
C-terminal domain in the absence of DNA. It has recently
been shown that the presence of an 8-oxoguanine site of
DNA damage in a DNA duplex causes the catalytic tyrosine
residue of human topoisomerase I to rotate away from the
remaining active site residues (Lesher et al., 2002). Such
a rearrangement is reminiscent of the tyrosine recombinases
and integrases that have also been shown to dock their
catalytic tyrosines away from their active site residues,
perhaps to regulate enzyme catalysis (Guo et al., 1997;
Kwon et al., 1997; Subramanya et al., 1997; Chen et al.,
2000). The C-terminal domain of topo70 remains relatively
rigid in the simulations presented here in the presence of
DNA. It would be of interest to examine whether the active
site or C-terminal domain of human topoisomerase I is more
dynamic in the absence of DNA.
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